ERC2: A Protein Wrapped in Controversy (G26059)

Target Name: ERC2

NCBI ID: G26059

ERC2

ERC2: A Protein Wrapped in Controversy

ERC2, also known as ELKS/RAB6-interacting protein 2, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the CAST family, which is a group of transcription factors that play a role in regulating gene expression. ERC2 has been shown to be involved in many different cellular processes, including cell signaling, DNA replication, and cell adhesion.

One of the key functions of ERC2 is its role in cell signaling. ERC2 has been shown to play a role in the regulation of cell proliferation and differentiation. It has been shown to promote the growth and survival of various cell types, and it has been shown to inhibit the growth and survival of cancer cells.

In addition to its role in cell signaling, ERC2 is also involved in many other cellular processes. For example, it is involved in the regulation of DNA replication, which is important for the maintenance of genetic accuracy. It is also involved in the regulation of cell adhesion, which is important for the formation of tissues and organs.

ERC2 has also been shown to play a role in the regulation of inflammation. It has been shown to promote the production of pro-inflammatory cytokines, which can contribute to the development of inflammation. It is also involved in the regulation of immune responses, which is important for the immune system's ability to fight off infections and diseases.

In conclusion, ERC2 is a protein that is involved in many different cellular processes. It is a potential drug target and may be useful for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of ERC2 in cell signaling and its potential as a drug target.

Protein Name: ELKS/RAB6-interacting/CAST Family Member 2

Functions: Thought to be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. Seems to act together with BSN. May recruit liprin-alpha proteins to the CAZ

The "ERC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ERC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets